Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Researchclopedia

Back to institutions

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Camperdownnonprofit

144

Works

15,954

Citations

59

h-index

Top Research Topics

Prostate Cancer Treatment and Research Bladder and Urothelial Cancer Treatments Radiopharmaceutical Chemistry and Applications

Top Researchers

Phyllis Butow The University of Sydney

899 works50,382 citationsh-index: 116

Recent Research

Development and validation of computational histology artificial intelligence (CHAI)–powered prognostic and predictive biomarkers in metastatic hormone-sensitive prostate cancer (mHSPC) using ENZAMET and CHAARTED prospective randomized phase 3 trials (RCT).

Neeraj Agarwal,Georges Gebrael,et al.

20260 citations

Prostate Cancer Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Urinary and Genital Oncology Studies

Renal cell carcinoma treatment

Cancer Genomics and Diagnostics

Testicular diseases and treatments

Cancer, Lipids, and Metabolism

Renal and related cancers

Cancer survivorship and care

Ray McDermott Cancer Trials Ireland

491 works38,462 citationsh-index: 62

Howard Gurney Macquarie University

452 works36,475 citationsh-index: 64

Shahneen Sandhu Royal Women's Hospital

642 works35,153 citationsh-index: 81

David Goldstein Engelhardt Institute of Molecular Biology

682 works31,298 citationsh-index: 81

Anthony M. Joshua Garvan Institute of Medical Research

765 works30,914 citationsh-index: 70

Initial results from CLIMATE, a prospective cohort study assessing the clinical utility of miR-371a-3p (miR-371) as a marker of minimal residual disease (MRD) in clinical stage 1 testicular germ cell tumour (TGCT): ANZUP 1906.

Ben Tran,Jeremy Lewin,et al.

20260 citations

SUBDUE‐3: SUB‐urothelial DUrvalumab‐ <sup>89</sup> zirconium injEction; a phase 0 biodistribution study protocol

K.G. Keane,Richard Gauci,et al.

20260 citations

WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide

Barak Talmor,Carole A. Harris,et al.

20260 citations

Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304)

Andrisha-Jade Inderjeeth,Andrew J. Martin,et al.

20260 citations

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

Soumyajit Roy,Yilun Sun,et al.

20250 citations